BRACONI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 6.002
EU - Europa 5.460
AS - Asia 678
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 8
AF - Africa 4
Totale 12.172
Nazione #
US - Stati Uniti d'America 5.990
GB - Regno Unito 1.865
IT - Italia 837
IE - Irlanda 814
CN - Cina 540
SE - Svezia 475
DE - Germania 440
UA - Ucraina 418
FR - Francia 263
FI - Finlandia 150
BE - Belgio 80
TR - Turchia 46
ES - Italia 41
IN - India 23
IR - Iran 22
NL - Olanda 17
VN - Vietnam 16
AT - Austria 15
CA - Canada 12
RU - Federazione Russa 12
AU - Australia 9
PK - Pakistan 8
EU - Europa 7
JP - Giappone 6
SG - Singapore 6
SK - Slovacchia (Repubblica Slovacca) 6
HU - Ungheria 4
PL - Polonia 4
RO - Romania 4
DK - Danimarca 3
GR - Grecia 3
JO - Giordania 3
NZ - Nuova Zelanda 3
PE - Perù 3
SA - Arabia Saudita 3
AR - Argentina 2
BG - Bulgaria 2
PT - Portogallo 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
HK - Hong Kong 1
IL - Israele 1
IM - Isola di Man 1
LB - Libano 1
LT - Lituania 1
MT - Malta 1
NG - Nigeria 1
PH - Filippine 1
TH - Thailandia 1
Totale 12.172
Città #
Southend 1.712
Fairfield 878
Dublin 804
Menlo Park 730
Chandler 570
Ashburn 415
Woodbridge 400
Jacksonville 347
Wilmington 331
Siena 329
Seattle 299
Houston 293
Cambridge 276
Ann Arbor 238
Princeton 164
Nanjing 116
Beijing 115
Helsinki 86
Brussels 78
San Mateo 59
New York 58
Boardman 57
Florence 57
Shanghai 48
Dearborn 46
Fremont 46
Nanchang 43
San Diego 42
Izmir 38
Milan 37
Lancaster 33
Shenyang 30
Málaga 29
London 23
Hebei 22
Redwood City 21
Rome 20
Norwalk 19
Tianjin 19
Changsha 18
Jiaxing 18
Dong Ket 16
Kunming 15
Renton 15
Vienna 14
Monteroni D'arbia 12
Zhengzhou 12
Curtarolo 11
Düsseldorf 11
Los Angeles 11
University Park 11
Washington 11
Nürnberg 9
Delhi 8
Guangzhou 8
Hangzhou 8
Verona 8
Jinan 7
San Francisco 7
Stockholm 7
Taizhou 7
Toronto 7
Eboli 6
Hefei 6
Ningbo 6
Pisa 6
Prato 6
Venezia 6
Borgo San Lorenzo 5
Bratislava 5
Castelfiorentino 5
Faisalabad 5
Kilburn 5
Philadelphia 5
Prescot 5
Sacramento 5
Tappahannock 5
Zanjan 5
Bonndorf 4
Canberra 4
Changchun 4
Floral Park 4
Groningen 4
Grosseto 4
Haikou 4
Hanover 4
Kocaeli 4
Leawood 4
Pewaukee 4
Redmond 4
Anguillara Sabazia 3
Atlanta 3
Auburn Hills 3
Auckland 3
Bangalore 3
Brentford 3
Busto Arsizio 3
Chicago 3
Chiusi 3
Città Di Castello 3
Totale 9.343
Nome #
Chondroptosis in alkaptonuric cartilage 321
Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria 276
Histological and Ultrastructural Characterization of Alkaptonuric Tissues 267
Smoothened-antagonists reverse homogentisic acid-induced alterations of Hedgehog signaling and primary cilium length in alkaptonuria 257
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients 238
Amyloidosis, Inflammation, and Oxidative Stress in the Heart of an Alkaptonuric Patient. 229
A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria 221
Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project 217
4-Hydroxyphenylpyruvate Dioxygenase and Its Inhibition in Plants and Animals: Small Molecules as Herbicides and Agents for the Treatment of Human Inherited Diseases 211
Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure. 210
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. 210
Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins 209
Beer promotes differentiation and mineralization of human osteoblastic cells: Role of silicon 209
Biochemical and proteomic characterization of alkaptonuric chondrocytes 203
Oxidative stress and mechanisms of ochronosis in alkaptonuria 195
Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. 183
Alkaptonuria is a novel human secondary amyloidogenic disease 181
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes 179
Effects of selenium on oxidative damage and antioxidant enzymes of eukaryotic cells: wine Saccharomyces cerevisiae 179
Secondary amyloidosis in an alkaptonuric aortic valve. 178
Diagnosis of secondary amyloidosis in alkaptonuria. 173
Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria 171
Foodomics for human health: current status and perspectives 170
Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress 166
Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes 165
Angiogenesis in alkaptonuria 163
Machine learning application for patient stratification and phenotype/genotype investigation in a rare disease 162
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis 162
Wild-type wine Saccharomyces cerevisiae as a tool to evaluate the effects on eukaryotic life of locally used herbicides 160
null 158
Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease 158
An Introduction to Personalized Nutrition 157
Prevalence of isolated atrial amyloidosis in young patients affected by congestive heart failure 155
Proteomics and redox-proteomics of the effects of herbicides on a wild-type wine Saccharomyces cerevisiae strain 153
Helicobacter pylori: immunoproteomics related to different pathologies 153
Machine learning application for development of a data-driven predictive model able to investigate quality of life scores in a rare disease 152
Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis 152
null 150
Post-genomics of bone metabolic dysfunctions and neoplasias. 147
Saccharomyces cerevisiae as a Tool to Evaluate the Effects of Herbicides on Eukaryotic Life 146
Amyloidosis in alkaptonuria 140
Comparative analysis of the effects of locally used herbicides and their active ingredients on a wild-type wine Saccharomyces cerevisiae strain 137
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model 137
Yield Determination of Bioethanol Production of Saccharomyces Cerevisiae Metabolic Process by Mathematical Modelling and In-Vivo 13C-NMR 136
Surfome analysis of a wild-type wine Saccharomyces cerevisiae strain. 135
Redox proteomics gives insights into the role of oxidative stress in alkaptonuria. 134
Mapping phosphoproteins in Neisseria meningitidis serogroup A 133
Metabolic response to exogenous ethanol in yeast: an in vivo NMR and mathematical modelling approach 133
null 131
Oxidative damage induced by herbicides is mediated by thiol oxidation and hydroperoxides production 130
Linking protein oxidation to environmental pollutants: redox proteomic approaches 128
Oxidative damage mediated by herbicides on yeast cells 127
Membrane Skeletal Protein S-Glutathionylation in Human Red Blood Cells as Index of Oxidative Stress 127
Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria 127
In vivo NMR study of yeast fermentative metabolism in the presence of ferric irons 125
Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria. 124
Omics-based technologies for food authentication and traceability 119
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial 118
Personalized nutrition and omics technologies 118
Postgenomics of Neisseria meningitidis: An update 117
Post-genomics and skin inflammation 116
Supportive use of cyclodextrins as decontamination agents for herbicides 112
Cell and tissue models of alkaptonuria 111
Omics Perspectives in Food Science 107
Antibacterial activity of grape extracts towards cagA positive and cagA negative Helicobacter pylori clinical isolates 105
Expanding the proteome database of Meningococcus A 105
Rubus ulmifolius Leaf Extract Inhibits Proliferation of Murine Myeloma Cells 99
The therapy for Helicobacter pylori eradication 98
Sub-lethal ethanol exposure enhances viability and ethanol production in Saccharomyces cerevisiae 97
The analysis of Neisseria meningitidis proteomes: reference maps and their applications 92
Diagnosis of Helicobacter pylori infection 91
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria 86
Identification of Helicobacter pylori proteins involved in metronidazole resistance by comparative proteomic analysis 82
Bacterial post-genomics approaches for vaccines development 82
Post-genomics of Neisseria meningitidis: an update 79
Postgenomics of Neisseria meningitidis for vaccines development 79
Leveraging proteomics in orphan disease research: pitfalls and potential 78
Novel identification of expressed genes and functional classification of hypothetical proteins from Neisseria meningitidis serogroup A 76
Subclinical ochronosis features in alkaptonuria: a cross-sectional study 70
Proteomics in plant research 69
Models of rare diseases 61
Helicobacter pylori infection and extra-digestive diseases 60
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies 58
Kinetics of different processes in human ANP amyloid formation 57
Helicobacter pylori VacA and CagA virulence factors 53
Survey on the Recent Advances in 4-Hydroxyphenylpyruvate Dioxygenase (HPPD) Inhibition by Diketone and Triketone Derivatives and Congeneric Compounds: Structural Analysis of HPPD/Inhibitor Complexes and Structure-Activity Relationship Considerations 46
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. 30
Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria 26
Saccharomyces cerevisiae as a model in ecotoxicological studies: A post-genomics perspective 24
Totale 12.371
Categoria #
all - tutte 32.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.023 0 0 0 0 0 0 0 0 175 173 351 324
2019/20202.399 306 96 150 338 174 185 209 286 212 192 83 168
2020/20212.098 98 153 84 224 169 219 98 262 185 331 156 119
2021/20221.586 139 173 118 121 77 62 83 60 86 193 161 313
2022/20231.906 120 190 242 256 179 352 73 159 175 48 60 52
2023/20241.224 55 36 137 76 72 366 440 38 4 0 0 0
Totale 12.371